Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer (PFE) offers potential 20-30% upside despite revenue risks. Explore its valuation, pipeline prospects, and dividend ...

This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

Pfizer Inc. is a global biopharmaceutical leader with a diversified product portfolio and significant scale, supported by ...

The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

One Louisiana woman, Robin Phillip, said she developed an intracranial meningioma that caused her to lose vision in her left ...

The deal is part of Trump's broader effort to tie the amount the government pays for certain drugs to the prices paid ...

Pfizer made a deal with the administration to implement President Donald Trump's Most Favored Nation drug pricing policies.

President Donald Trump announced a deal with Pfizer to lower drug prices for some Americans. The White House is also unveiling a TrumpRx website.

(Reuters) -Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor ...

Pfizer is facing lawsuits from over a thousand women who claim they developed brain tumors after using the company's ...